Details for Patent: 9,687,465
✉ Email this page to a colleague
Which drugs does patent 9,687,465 protect, and when does it expire?
Patent 9,687,465 protects EPSOLAY and is included in one NDA.
Summary for Patent: 9,687,465
Title: | Compositions for the treatment of rosacea |
Abstract: | The present invention relates to pharmaceutical compositions for topical use (including also dermatological compositions), for treating skin conditions and afflictions, such as rosacea and symptoms and conditions associated there from. |
Inventor(s): | Sertchook; Hanan (Gedera, IL), Toledano; Ofer (Kfar-Saba, IL), Bar-Simantov; Haim (Modi'in, IL) |
Assignee: | SOL-GEL TECHNOLOGIES LTD. (Ness Ziona, IL) |
Application Number: | 13/686,533 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; | More… ↓ |
Drugs Protected by US Patent 9,687,465
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galderma Labs Lp | EPSOLAY | benzoyl peroxide | CREAM;TOPICAL | 214510-001 | Apr 22, 2022 | RX | Yes | Yes | 9,687,465 | ⤷ Subscribe | Y | TOPICAL TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA IN ADULTS 18 YEARS OF AGE AND OLDER | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |